Profil
Jeffrey Trotter is the founder of Ovation Healthcare Research 2, Inc. He currently holds two positions, Senior Vice President at Worldwide Clinical Trials LLC since 2018 and Operating Advisor at Revival Healthcare Capital LLC.
Previously, he worked as Executive Vice President-Phase IV Development at inVentiv Health Clinical, Inc. and as President at Continuum Clinical LLC.
Mr. Trotter has an MBA from Kellogg School of Management and an undergraduate degree from the University of Illinois At Urbana–Champaign.
Postes actifs de Jeffrey Trotter
| Sociétés | Poste | Début |
|---|---|---|
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Consultant / Advisor | - |
Worldwide Clinical Trials LLC
Worldwide Clinical Trials LLC Pharmaceuticals: MajorHealth Technology Operates as a contract research organization that develops therapeutics for neuroscience, oncology, rare diseases and cardiometabolic disorders | Corporate Officer/Principal | 01/03/2018 |
Anciens postes connus de Jeffrey Trotter
| Sociétés | Poste | Fin |
|---|---|---|
Continuum Clinical LLC
Continuum Clinical LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial enrollment company | President | - |
Ovation Healthcare Research 2, Inc.
Ovation Healthcare Research 2, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health economics, patient registries, outcomes research and consulting services | Fondateur | - |
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Corporate Officer/Principal | - |
Formation de Jeffrey Trotter
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 7 |
|---|---|
inVentiv Health Clinical, Inc.
inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
Ovation Healthcare Research 2, Inc.
Ovation Healthcare Research 2, Inc. Miscellaneous Commercial ServicesCommercial Services Provides health economics, patient registries, outcomes research and consulting services | Commercial Services |
Worldwide Clinical Trials LLC
Worldwide Clinical Trials LLC Pharmaceuticals: MajorHealth Technology Operates as a contract research organization that develops therapeutics for neuroscience, oncology, rare diseases and cardiometabolic disorders | Health Technology |
Kellogg School of Management
Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Continuum Clinical LLC
Continuum Clinical LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical trial enrollment company | Commercial Services |
University of Illinois At Urbana–Champaign
University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Revival Healthcare Capital LLC
Revival Healthcare Capital LLC Investment ManagersFinance Revival Healthcare Capital invests in companies located in the United States with an enterprise value of USD 150 million - 1 billion and revenue of USD 10 - 500 million. The firm targets companies operating in the fields of healthcare, technology, medical devices and diagnostics sectors. It provides financing for buyout, recapitalization and growth stage capital requirements with an investment size of USD 10 - 250 million. The firm acquires majority, minority and controlling interest and makes co-investments. It also acts as a lead investor. | Finance |
















